3-methyl-5-oxo-5,8-dihydro[1,2,4]triazolo[4,3-a]pyrimidine-6-carboxylic acid hydrate, 95.0%, 500mg

tert-Butyl 3-nitro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate, 95.0%, 25g

1,2-Bis(dimethylsilyl)benzene>94.0%(GC)1mL

Danger signs SEKUROKA® Radioactive, 1 Roll

5-Bromo-2,4-difluorobenzaldehyde, 95.0%, 10g

2-(2-methyl-1H-imidazol-1-yl)ethanol, 95.0%, 1g

2-Oxo-6-phenyl-4-(trifluoromethyl)-1,2-dihydro-3-pyridinecarbonitrile, 95.0%, 250mg

Phenylmethylsiloxane homopolymer, 500 cSt, 100g

Ethyl Nicotinate>99.0%(GC)100mL

2-(1-(2-Hydroxy-3,5-di-tert-pentylphenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate, 98%, 25g

1,3-Dibromo-5-fluoro-2-methylbenzene, 98%, 100g

4-Pyridinecarboxamide, 2-(cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-, 98%, 5mg

8-Chloro-4-((3-chloro-4-fluorophenyl)amino)-6-nitroquinoline-3-carbonitrile, 98%, 100mg